Varun Sharma visits the wider AMIDS area during early location diligence
The photograph records presence in the wider area only. It does not establish parcel access, site control, approval, partnership or construction.
Owned editorial
Evidence-led analysis, evidence-controlled development records and open diligence questions from VARUNÉ Labs Scotland. These pages are owned editorial, not independent press coverage. Sources provide context, not endorsement or access.
Company news
Owned editorial from VARUNÉ Labs. Plans are not approvals, discussions are not partnerships and concept imagery is not an operating record.
The photograph records presence in the wider area only. It does not establish parcel access, site control, approval, partnership or construction.
The corridor is the preferred Scottish area for the next stage of location work, with no binding commitment.
The founder sets out a partner-first, evidence-first and reversible approach to the proposed campus programme.
VARUNÉ insights
A responsibility map for brand rights, formulation, manufacturing, distribution, creative control and cosmetic regulation, with no VARUNÉ product or launch announcement.
An evidence-led analysis of the infrastructure, operating model and governance that make a science campus credible.
Why VARUNÉ Labs is evaluating the AMIDS and Glasgow Airport corridor, and which facts must be proven before any site decision.
How formulation, analytical understanding, quality risk management and life-cycle learning can inform future medicines infrastructure.
A governance-first view of how future AI, robotics and connected laboratory systems could support medicines operations.